Therapeutic potential of statins in thyroid proliferative disease

Nat Clin Pract Endocrinol Metab. 2008 May;4(5):242-3. doi: 10.1038/ncpendmet0782. Epub 2008 Feb 26.

Author

Maurizio Bifulco¹

Affiliation

¹ Department of Pharmaceutical Sciences, University of Salerno, Via Ponte Don Melillo, 84084 Fisciano (Salerno), Italy. maubiful@unisa.it

PMID: 18301396
DOI: 10.1038/ncpendmet0782

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Apoptosis / drug effects
Cell Growth Processes / drug effects
Cell Line, Tumor
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Lovastatin / pharmacology
Lovastatin / therapeutic use
Thyroid Neoplasms / drug therapy*
Thyroid Neoplasms / pathology

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lovastatin